P. Deny and F. Zoulim, Hepatitis B virus: From diagnosis to treatment, Pathologie Biologie, vol.58, issue.4, pp.245-53, 2010.
DOI : 10.1016/j.patbio.2010.05.002

Y. Shi and C. Shi, Molecular characteristics and stages of chronic hepatitis B virus infection, World Journal of Gastroenterology, vol.15, issue.25, pp.3099-105, 2009.
DOI : 10.3748/wjg.15.3099

R. Takkenberg, C. Weegink, and H. Zaaijer, New developments in antiviral therapy for chronic hepatitis B, Vox Sanguinis, vol.48, issue.3, pp.481-94, 2010.
DOI : 10.1111/j.1423-0410.2009.01282.x

F. Zoulim and S. Locarnini, Hepatitis B Virus Resistance to Nucleos(t)ide Analogues, Gastroenterology, vol.137, issue.5, pp.1593-608, 2009.
DOI : 10.1053/j.gastro.2009.08.063

M. Jung and G. Pape, Immunology of hepatitis B infection, The Lancet Infectious Diseases, vol.2, issue.1, pp.43-50, 2002.
DOI : 10.1016/S1473-3099(01)00172-4

L. Guidotti and F. Chisari, IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS, Annual Review of Pathology: Mechanisms of Disease, vol.1, issue.1, pp.23-61, 2006.
DOI : 10.1146/annurev.pathol.1.110304.100230

M. Maini, C. Boni, and C. Lee, Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection, The Journal of Experimental Medicine, vol.68, issue.8, pp.1269-80, 2000.
DOI : 10.1084/jem.188.12.2205

G. Webster, S. Reignat, and D. Brown, Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy, Journal of Virology, vol.78, issue.11, pp.5707-5726, 2004.
DOI : 10.1128/JVI.78.11.5707-5719.2004

B. Rehermann, D. Lau, and J. Hoofnagle, Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection., Journal of Clinical Investigation, vol.97, issue.7, pp.1655-65, 1996.
DOI : 10.1172/JCI118592

M. Maini, C. Boni, and G. Ogg, Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection, Gastroenterology, vol.117, issue.6, pp.1386-96, 1999.
DOI : 10.1016/S0016-5085(99)70289-1

A. Penna, F. Chisari, and A. Bertoletti, Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen, Journal of Experimental Medicine, vol.174, issue.6, pp.1565-70, 1991.
DOI : 10.1084/jem.174.6.1565

R. Nayersina, P. Fowler, and S. Guilhot, HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection, J Immunol, vol.150, pp.4659-71, 1993.

B. Rehermann, P. Fowler, and J. Sidney, The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis, Journal of Experimental Medicine, vol.181, issue.3, pp.1047-58, 1995.
DOI : 10.1084/jem.181.3.1047

N. Shimada, K. Yamamoto, and M. Kuroda, HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells, Journal of Clinical Immunology, vol.23, issue.3, pp.223-255, 2003.
DOI : 10.1023/A:1023366013858

P. Yang, A. Althage, and J. Chung, Immune effectors required for hepatitis B virus clearance, Proceedings of the National Academy of Sciences, vol.107, issue.2, pp.798-802, 2010.
DOI : 10.1073/pnas.0913498107

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818933

G. Lau, D. Suri, and R. Liang, Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen, Gastroenterology, vol.122, issue.3, pp.614-638, 2002.
DOI : 10.1053/gast.2002.31887

A. Das, M. Hoare, and N. Davies, Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection, The Journal of Experimental Medicine, vol.163, issue.9, pp.2111-2135, 2008.
DOI : 10.1128/JVI.79.14.8960-8968.2005

P. Fisicaro, C. Valdatta, and M. Massari, Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B, Gastroenterology, vol.138, issue.2, pp.682-93, 2010.
DOI : 10.1053/j.gastro.2009.09.052

D. Loirat, F. Lemonnier, and M. Michel, Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization, The Journal of Immunology, vol.165, issue.8, pp.4748-55, 2000.
DOI : 10.4049/jimmunol.165.8.4748

E. Depla, A. Van-der-aa, and B. Livingston, Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections, Journal of Virology, vol.82, issue.1, pp.435-50, 2008.
DOI : 10.1128/JVI.01505-07

B. Livingston, C. Crimi, and H. Grey, The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection, J Immunol, vol.159, pp.1383-92, 1997.

W. Chen, M. Shi, and F. Shi, HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes, Hepatology Research, vol.60, issue.9, pp.355-65, 2009.
DOI : 10.1111/j.1872-034X.2008.00468.x

A. Gehring, S. Xue, and Z. Ho, Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines, Journal of Hepatology, vol.55, issue.1, pp.103-113, 2010.
DOI : 10.1016/j.jhep.2010.10.025

F. Bohne, M. Chmielewski, and G. Ebert, T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes, Gastroenterology, vol.134, issue.1, pp.239-286, 2008.
DOI : 10.1053/j.gastro.2007.11.002

URL : http://mediatum.ub.tum.de/doc/676331/document.pdf

F. Zoulim, P. Berthillon, and F. Guerhier, Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies, Journal of Gastroenterology and Hepatology, vol.44, issue.s4, 2002.
DOI : 10.1016/S0168-8278(98)80191-8

W. Barchet, M. Cella, and M. Colonna, Plasmacytoid dendritic cells???virus experts of innate immunity, Seminars in Immunology, vol.17, issue.4, pp.253-61, 2005.
DOI : 10.1016/j.smim.2005.05.008

B. Reizis, A. Bunin, and H. Ghosh, Plasmacytoid Dendritic Cells: Recent Progress and Open Questions, Annual Review of Immunology, vol.29, issue.1, pp.163-83, 2011.
DOI : 10.1146/annurev-immunol-031210-101345

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160806

M. Colonna, G. Trinchieri, and Y. Liu, Plasmacytoid dendritic cells in immunity, Nature Immunology, vol.165, issue.12, pp.1219-1245, 2004.
DOI : 10.1038/32588

J. Villadangos and L. Young, Antigen-Presentation Properties of Plasmacytoid Dendritic Cells, Immunity, vol.29, issue.3, pp.352-61, 2008.
DOI : 10.1016/j.immuni.2008.09.002

G. Lui, O. Manches, and J. Angel, Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells, PLoS ONE, vol.304, issue.9, p.7111, 2009.
DOI : 10.1371/journal.pone.0007111.g006

URL : https://hal.archives-ouvertes.fr/inserm-00419345

J. Fonteneau, M. Gilliet, and M. Larsson, Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity, Blood, vol.101, issue.9, pp.3520-3526, 2003.
DOI : 10.1182/blood-2002-10-3063

G. Schlecht, S. Garcia, and N. Escriou, Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation, Blood, vol.104, issue.6, pp.1808-1823, 2004.
DOI : 10.1182/blood-2004-02-0426

URL : https://hal.archives-ouvertes.fr/pasteur-00327333

L. Chaperot, A. Blum, and O. Manches, Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells, The Journal of Immunology, vol.176, issue.1, pp.248-55, 2006.
DOI : 10.4049/jimmunol.176.1.248

URL : https://hal.archives-ouvertes.fr/inserm-00286442

C. Aspord, J. Charles, and M. Leccia, A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells, PLoS ONE, vol.5, issue.5, p.10458, 2010.
DOI : 10.1371/journal.pone.0010458.s010

URL : https://hal.archives-ouvertes.fr/inserm-00484505

A. Gehring, D. Sun, and P. Kennedy, The Level of Viral Antigen Presented by Hepatocytes Influences CD8 T-Cell Function, Journal of Virology, vol.81, issue.6, pp.2940-2949, 2007.
DOI : 10.1128/JVI.02415-06

J. Stoop, R. Van-der-molen, and C. Baan, Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection, Hepatology, vol.3, issue.4, pp.771-779, 2005.
DOI : 10.1002/hep.20649

D. Xu, J. Fu, and L. Jin, Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B, The Journal of Immunology, vol.177, issue.1, pp.739-786, 2006.
DOI : 10.4049/jimmunol.177.1.739

O. Franzese, P. Kennedy, and A. Gehring, Modulation of the CD8+-T-Cell Response by CD4+ CD25+ Regulatory T Cells in Patients with Hepatitis B Virus Infection, Journal of Virology, vol.79, issue.6, pp.3322-3330, 2005.
DOI : 10.1128/JVI.79.6.3322-3328.2005

M. Chen, J. Billaud, and M. Sallberg, A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen, Proceedings of the National Academy of Sciences, vol.101, issue.41, pp.14913-14921, 2004.
DOI : 10.1073/pnas.0406282101

J. Luo, J. Li, R. Chen, and L. Nie, Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers, Vaccine, vol.28, issue.13, pp.2497-504, 2010.
DOI : 10.1016/j.vaccine.2010.01.038

E. Ilan, J. Arazi, and O. Nussbaum, The Hepatitis C Virus (HCV)???Trimera Mouse: A Model for Evaluation of Agents against HCV, The Journal of Infectious Diseases, vol.185, issue.2, pp.153-61, 2002.
DOI : 10.1086/338266

P. Meuleman and G. Leroux-roels, The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCV, Antiviral Research, vol.80, issue.3, pp.231-239, 2008.
DOI : 10.1016/j.antiviral.2008.07.006

F. Chisari, Hepatitis B Virus Transgenic Mice: Models of Viral Immunobiology and Pathogenesis, Curr Top Microbiol Immunol, vol.206, pp.149-73, 1996.
DOI : 10.1007/978-3-642-85208-4_9

T. Shi, Y. Wu, and Z. Jia, Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice, World J Gastroenterol, vol.10, pp.1222-1228, 2004.

C. Boni, A. Penna, and A. Bertoletti, Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B, Journal of Hepatology, vol.39, issue.4, pp.595-605, 2003.
DOI : 10.1016/S0168-8278(03)00292-7

A. Lok and B. Mcmahon, Chronic hepatitis B, Hepatology, vol.4, issue.RR-16, pp.507-546, 2007.
DOI : 10.1002/hep.21513

Y. Shi and C. Shi, Molecular characteristics and stages of chronic hepatitis B virus infection, World Journal of Gastroenterology, vol.15, issue.25, pp.3099-105, 2009.
DOI : 10.3748/wjg.15.3099

J. Summers, O. Connell, A. Millman, and I. , Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles., Proceedings of the National Academy of Sciences, vol.72, issue.11, pp.4597-601, 1975.
DOI : 10.1073/pnas.72.11.4597

D. Dane, C. Cameron, and M. Briggs, VIRUS-LIKE PARTICLES IN SERUM OF PATIENTS WITH AUSTRALIA-ANTIGEN-ASSOCIATED HEPATITIS, The Lancet, vol.295, issue.7649, pp.695-703, 1970.
DOI : 10.1016/S0140-6736(70)90926-8

W. Robinson and L. Lutwick, The Virus of Hepatitis, Type B, New England Journal of Medicine, vol.295, issue.21, pp.1168-75, 1976.
DOI : 10.1056/NEJM197611182952105

D. Ganem, Assembly of Hepadnaviral Virions and Subviral Particles, Curr Top Microbiol Immunol, vol.168, pp.61-83, 1991.
DOI : 10.1007/978-3-642-76015-0_4

K. Takahashi, A. Machida, G. Funatsu, M. Nomura, S. Usuda et al., Immunochemical structure of hepatitis B e antigen in the serum, J Immunol, vol.130, pp.2903-2910, 1983.

S. Benhenda, D. Cougot, M. Buendia, and C. Neuveut, Chapter 4 Hepatitis B Virus X Protein, Adv Cancer Res, vol.103, pp.75-109, 2009.
DOI : 10.1016/S0065-230X(09)03004-8

J. Summers and W. Mason, Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate, Cell, vol.29, issue.2, pp.403-418, 1982.
DOI : 10.1016/0092-8674(82)90157-X

M. Levrero, T. Pollicino, J. Petersen, L. Belloni, G. Raimondo et al., Control of cccDNA function in hepatitis B virus infection, Journal of Hepatology, vol.51, issue.3, pp.581-92, 2009.
DOI : 10.1016/j.jhep.2009.05.022

J. Pollack and D. Ganem, Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis, J Virol, vol.68, pp.5579-87, 1994.

J. Tuttleman, C. Pourcel, and J. Summers, Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells, Cell, vol.47, issue.3, pp.451-60, 1986.
DOI : 10.1016/0092-8674(86)90602-1

L. Guidotti and F. Chisari, IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS, Annual Review of Pathology: Mechanisms of Disease, vol.1, issue.1, pp.23-61, 2006.
DOI : 10.1146/annurev.pathol.1.110304.100230

F. Chisari and C. Ferrari, Hepatitis B Virus Immunopathogenesis, Annual Review of Immunology, vol.13, issue.1, pp.29-60, 1995.
DOI : 10.1146/annurev.iy.13.040195.000333

G. Webster, S. Reignat, D. Brown, G. Ogg, L. Jones et al., Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy, Journal of Virology, vol.78, issue.11, pp.5707-5726, 2004.
DOI : 10.1128/JVI.78.11.5707-5719.2004

M. Maini, C. Boni, C. Lee, J. Larrubia, S. Reignat et al., Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection, The Journal of Experimental Medicine, vol.68, issue.8, pp.1269-80, 2000.
DOI : 10.1084/jem.188.12.2205

L. Guidotti, T. Ishikawa, M. Hobbs, B. Matzke, R. Schreiber et al., Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes, Immunity, vol.4, issue.1, pp.25-36, 1996.
DOI : 10.1016/S1074-7613(00)80295-2

M. Maini, C. Boni, G. Ogg, A. King, S. Reignat et al., Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection, Gastroenterology, vol.117, issue.6, pp.1386-96, 1999.
DOI : 10.1016/S0016-5085(99)70289-1

A. Penna, F. Chisari, A. Bertoletti, G. Missale, P. Fowler et al., Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen, Journal of Experimental Medicine, vol.174, issue.6, pp.1565-70, 1991.
DOI : 10.1084/jem.174.6.1565

N. Shimada, K. Yamamoto, M. Kuroda, R. Terada, T. Hakoda et al., HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells, Journal of Clinical Immunology, vol.23, issue.3, pp.223-255, 2003.
DOI : 10.1023/A:1023366013858

J. Brown, W. Carman, and H. Thomas, The hepatitis B virus, Bailli??re's Clinical Gastroenterology, vol.4, issue.3, pp.721-768, 1990.
DOI : 10.1016/0950-3528(90)90059-P

L. Wang, S. Lin, J. Tsai, C. Tsai, C. Tsai et al., Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection

K. Hu, Occult hepatitis B virus infection and its clinical implications, Journal of Viral Hepatitis, vol.17, issue.4, pp.243-57, 2002.
DOI : 10.1007/s007050050099

M. Jung and G. Pape, Immunology of hepatitis B infection, The Lancet Infectious Diseases, vol.2, issue.1, pp.43-50, 2002.
DOI : 10.1016/S1473-3099(01)00172-4

F. Chisari, Hepatitis B Virus Transgenic Mice: Models of Viral Immunobiology and Pathogenesis, Curr Top Microbiol Immunol, vol.206, pp.149-73, 1996.
DOI : 10.1007/978-3-642-85208-4_9

R. Thimme, S. Wieland, C. Steiger, J. Ghrayeb, K. Reimann et al., CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection, Journal of Virology, vol.77, issue.1, pp.68-76, 2003.
DOI : 10.1128/JVI.77.1.68-76.2003

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC140637

H. Yang, S. Lu, Y. Liaw, S. You, C. Sun et al., Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma, New England Journal of Medicine, vol.347, issue.3, pp.168-74, 2002.
DOI : 10.1056/NEJMoa013215

D. Milich, F. Schodel, J. Hughes, J. Jones, and D. Peterson, The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype, J Virol, vol.71, pp.2192-201, 1997.

M. Chen, J. Billaud, M. Sallberg, L. Guidotti, F. Chisari et al., A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen, Proceedings of the National Academy of Sciences, vol.101, issue.41, pp.14913-14921, 2004.
DOI : 10.1073/pnas.0406282101

M. Brunetto, M. Giarin, F. Oliveri, G. Saracco, C. Barbera et al., ???e??? Antigen defective hepatitis B virus and course of chronic infection, Journal of Hepatology, vol.13, issue.4, pp.82-88, 1991.
DOI : 10.1016/0168-8278(91)90031-6

J. Stoop, R. Van-der-molen, C. Baan, L. Van-der-laan, E. Kuipers et al., Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection, Hepatology, vol.3, issue.4, pp.771-779, 2005.
DOI : 10.1002/hep.20649

D. Xu, J. Fu, J. L. Zhang, H. Zhou, C. Zou et al., Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B, The Journal of Immunology, vol.177, issue.1, pp.739-786, 2006.
DOI : 10.4049/jimmunol.177.1.739

C. Miroux, T. Vausselin, and N. Delhem, Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response, Expert Opinion on Biological Therapy, vol.18, issue.6, pp.1563-72, 2010.
DOI : 10.1111/j.1440-1746.2009.06154.x

D. Bowen, M. Zen, L. Holz, T. Davis, G. Mccaughan et al., The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity, Journal of Clinical Investigation, vol.114, issue.5, pp.701-713, 2004.
DOI : 10.1172/JCI21593DS1

A. Gehring, D. Sun, P. Kennedy, E. Nolte-'t-hoen, S. Lim et al., The Level of Viral Antigen Presented by Hepatocytes Influences CD8 T-Cell Function, Journal of Virology, vol.81, issue.6, pp.2940-2949, 2007.
DOI : 10.1128/JVI.02415-06

S. Goldstein, F. Zhou, S. Hadler, B. Bell, E. Mast et al., A mathematical model to estimate global hepatitis B disease burden and vaccination impact, International Journal of Epidemiology, vol.34, issue.6, pp.1329-1368, 2005.
DOI : 10.1093/ije/dyi206

S. Pol, B. Nalpas, F. Driss, M. Michel, P. Tiollais et al., Efficacy and limitations of a specific immunotherapy in chronic hepatitis B, Journal of Hepatology, vol.34, issue.6, pp.917-938, 2001.
DOI : 10.1016/S0168-8278(01)00028-9

K. Yalcin, M. Acar, and H. Degertekin, Specific hepatitis B vaccine therapy in inactive HBsAg carriers: a randomized controlled trial, Infection, vol.31, pp.221-226, 2003.

M. Jung, N. Gruner, R. Zachoval, W. Schraut, T. Gerlach et al., Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers, Vaccine, vol.20, issue.29-30, pp.3598-612, 2002.
DOI : 10.1016/S0264-410X(02)00309-2

N. Horiike, F. Akbar, S. Michitaka, K. Joukou, K. Yamamoto et al., In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B, Journal of Clinical Virology, vol.32, issue.2, pp.156-61, 2005.
DOI : 10.1016/j.jcv.2004.07.004

E. Buster, B. Hansen, G. Lau, T. Piratvisuth, S. Zeuzem et al., Factors That Predict Response of Patients With Hepatitis B e Antigen???Positive Chronic Hepatitis B to Peginterferon-Alfa, Gastroenterology, vol.137, issue.6, pp.2002-2011, 2009.
DOI : 10.1053/j.gastro.2009.08.061

H. Janssen, M. Van-zonneveld, H. Senturk, S. Zeuzem, U. Akarca et al., Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial, The Lancet, vol.365, issue.9454, pp.123-132, 2005.
DOI : 10.1016/S0140-6736(05)17701-0

P. Marcellin, G. Lau, F. Bonino, P. Farci, S. Hadziyannis et al., Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B, New England Journal of Medicine, vol.351, issue.12, pp.1206-1223, 2004.
DOI : 10.1056/NEJMoa040431

K. Wursthorn, M. Lutgehetmann, M. Dandri, T. Volz, P. Buggisch et al., Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B, Hepatology, vol.46, issue.3, pp.675-84, 2006.
DOI : 10.1002/hep.21282

H. Senturk, B. Baysal, V. Tahan, H. Zerdali, R. Ozaras et al., Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection, Digestive Diseases and Sciences, vol.137, issue.1, pp.208-220, 2010.
DOI : 10.1007/s10620-010-1255-9

G. Fattovich, C. Betterle, L. Brollo, B. Pedini, G. Giustina et al., Autoantibodies during ??-interferon therapy for chronic hepatitis B, Journal of Medical Virology, vol.41, issue.2, pp.132-137, 1991.
DOI : 10.1002/jmv.1890340212

R. Takkenberg, C. Weegink, H. Zaaijer, and H. Reesink, New developments in antiviral therapy for chronic hepatitis B, Vox Sanguinis, vol.48, issue.3, pp.481-94, 2010.
DOI : 10.1111/j.1423-0410.2009.01282.x

G. Yao, M. Zhu, Z. Cui, B. Wang, J. Yao et al., A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China, Journal of Digestive Diseases, vol.44, issue.Suppl, pp.131-138, 2009.
DOI : 10.1111/j.1751-2980.2009.00375.x

J. Dienstag, J. Cianciara, S. Karayalcin, K. Kowdley, B. Willems et al., Durability of serologic response after lamivudine treatment of chronic hepatitis B, Hepatology, vol.9, issue.4, pp.748-55, 2003.
DOI : 10.1053/jhep.2003.50117

A. Lok, M. Hussain, C. Cursano, M. Margotti, A. Gramenzi et al., Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy, Hepatology, vol.32, pp.1145-53, 2000.

F. Zoulim and S. Locarnini, Hepatitis B Virus Resistance to Nucleos(t)ide Analogues, Gastroenterology, vol.137, issue.5, pp.1593-608, 2009.
DOI : 10.1053/j.gastro.2009.08.063

Y. Lee, D. Suh, Y. Lim, S. Jung, K. Kim et al., Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy, Hepatology, vol.51, issue.6, pp.1385-91, 2006.
DOI : 10.1002/hep.21189

D. Loirat, F. Lemonnier, and M. Michel, Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization, The Journal of Immunology, vol.165, issue.8, pp.4748-55, 2000.
DOI : 10.4049/jimmunol.165.8.4748

E. Depla, A. Van-der-aa, B. Livingston, C. Crimi, K. Allosery et al., Rational design of a multiepitope vaccine encoding Tlymphocyte epitopes for treatment of chronic hepatitis B virus infections

B. Livingston, C. Crimi, J. Fikes, R. Chesnut, J. Sidney et al., Immunization with the HBV core 18???27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules, Human Immunology, vol.60, issue.11, pp.1013-1020, 1999.
DOI : 10.1016/S0198-8859(99)00103-2

A. Gehring, S. Xue, Z. Ho, D. Teoh, C. Ruedl et al., Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines, Journal of Hepatology, vol.55, issue.1, pp.103-113, 2010.
DOI : 10.1016/j.jhep.2010.10.025

W. Chen, M. Shi, F. Shi, Y. Mao, Z. Tang et al., HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes, Hepatology Research, vol.60, issue.9, pp.355-65, 2009.
DOI : 10.1111/j.1872-034X.2008.00468.x

J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque et al., Immunobiology of Dendritic Cells, Annual Review of Immunology, vol.18, issue.1, pp.767-811, 2000.
DOI : 10.1146/annurev.immunol.18.1.767

M. Colonna, G. Trinchieri, and Y. Liu, Plasmacytoid dendritic cells in immunity, Nature Immunology, vol.165, issue.12, pp.1219-1245, 2004.
DOI : 10.1038/32588

S. Sozzani, W. Vermi, D. Prete, A. Facchetti, and F. , Trafficking properties of plasmacytoid dendritic cells in health and disease, Trends in Immunology, vol.31, issue.7, pp.270-277, 2010.
DOI : 10.1016/j.it.2010.05.004

G. Randolph, J. Ochando, and S. Partida-sanchez, Migration of Dendritic Cell Subsets and their Precursors, Annual Review of Immunology, vol.26, issue.1, pp.293-316, 2008.
DOI : 10.1146/annurev.immunol.26.021607.090254

A. Dzionek, Y. Sohma, J. Nagafune, M. Cella, M. Colonna et al., BDCA-2, a Novel Plasmacytoid Dendritic Cell???specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon ??/?? Induction, The Journal of Experimental Medicine, vol.147, issue.12, pp.1823-1857, 2001.
DOI : 10.1016/S0167-5699(00)01745-X

A. Dzionek, Y. Inagaki, K. Okawa, J. Nagafune, J. Rock et al., Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions, Human Immunology, vol.63, issue.12, pp.1133-1181, 2002.
DOI : 10.1016/S0198-8859(02)00752-8

Y. Liu, IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors, Annual Review of Immunology, vol.23, issue.1, pp.275-306, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115633

A. Iwasaki and R. Medzhitov, Toll-like receptor control of the adaptive immune responses, Nature Immunology, vol.169, issue.10, pp.987-95, 2004.
DOI : 10.1126/science.1076071

J. Lund, A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki, Toll-like Receptor 9???mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells, The Journal of Experimental Medicine, vol.83, issue.3, pp.513-533, 2003.
DOI : 10.1038/ni0901-835

M. Gilliet, W. Cao, and Y. Liu, Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases, Nature Reviews Immunology, vol.204, issue.8, pp.594-606, 2008.
DOI : 10.1038/nri2358

W. Barchet, M. Cella, and M. Colonna, Plasmacytoid dendritic cells???virus experts of innate immunity, Seminars in Immunology, vol.17, issue.4, pp.253-61, 2005.
DOI : 10.1016/j.smim.2005.05.008

L. Bon, A. Tough, and D. , Links between innate and adaptive immunity via type I interferon, Current Opinion in Immunology, vol.14, issue.4, pp.432-438, 2002.
DOI : 10.1016/S0952-7915(02)00354-0

N. Kadowaki, S. Antonenko, J. Lau, and Y. Liu, Natural Interferon ??/?????Producing Cells Link Innate and Adaptive Immunity, The Journal of Experimental Medicine, vol.157, issue.2, pp.219-245, 2000.
DOI : 10.1146/annurev.iy.12.040194.005015

C. Liu, Y. Lou, G. Lizee, H. Qin, S. Liu et al., Plasmacytoid dendritic cells induce NK cell???dependent, tumor antigen???specific T cell cross-priming and tumor regression in mice, Journal of Clinical Investigation, vol.118, pp.1165-75, 2008.
DOI : 10.1172/JCI33583

D. Agnello, C. Lankford, J. Bream, A. Morinobu, M. Gadina et al., Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights, Journal of Clinical Immunology, vol.23, issue.3, pp.147-61, 2003.
DOI : 10.1023/A:1023381027062

T. Ito, R. Amakawa, M. Inaba, T. Hori, M. Ota et al., Plasmacytoid Dendritic Cells Regulate Th Cell Responses through OX40 Ligand and Type I IFNs, The Journal of Immunology, vol.172, issue.7, pp.4253-4262, 2004.
DOI : 10.4049/jimmunol.172.7.4253

J. Fonteneau, M. Larsson, A. Beignon, K. Mckenna, I. Dasilva et al., Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells, Journal of Virology, vol.78, issue.10, pp.5223-5255, 2004.
DOI : 10.1128/JVI.78.10.5223-5232.2004

G. Jego, A. Palucka, J. Blanck, C. Chalouni, V. Pascual et al., Plasmacytoid Dendritic Cells Induce Plasma Cell Differentiation through Type I Interferon and Interleukin 6, Immunity, vol.19, issue.2, pp.225-259, 2003.
DOI : 10.1016/S1074-7613(03)00208-5

J. Villadangos and L. Young, Antigen-Presentation Properties of Plasmacytoid Dendritic Cells, Immunity, vol.29, issue.3, pp.352-61, 2008.
DOI : 10.1016/j.immuni.2008.09.002

G. Lui, O. Manches, J. Angel, J. Molens, L. Chaperot et al., Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells, PLoS ONE, vol.304, issue.9, p.7111, 2009.
DOI : 10.1371/journal.pone.0007111.g006

URL : https://hal.archives-ouvertes.fr/inserm-00419345

G. Hoeffel, A. Ripoche, D. Matheoud, M. Nascimbeni, N. Escriou et al., Antigen Crosspresentation by Human Plasmacytoid Dendritic Cells, Immunity, vol.27, issue.3, pp.481-92, 2007.
DOI : 10.1016/j.immuni.2007.07.021

URL : https://hal.archives-ouvertes.fr/pasteur-00360697

H. Yoneyama, K. Matsuno, E. Toda, T. Nishiwaki, N. Matsuo et al., Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs, The Journal of Experimental Medicine, vol.160, issue.3, pp.425-460, 2005.
DOI : 10.1084/jem.180.5.1889

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213078

G. Schlecht, S. Garcia, N. Escriou, A. Freitas, C. Leclerc et al., Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation, Blood, vol.104, issue.6, pp.1808-1823, 2004.
DOI : 10.1182/blood-2004-02-0426

URL : https://hal.archives-ouvertes.fr/pasteur-00327333

L. Chaperot, A. Blum, O. Manches, G. Lui, J. Angel et al., Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells, The Journal of Immunology, vol.176, issue.1, pp.248-55, 2006.
DOI : 10.4049/jimmunol.176.1.248

URL : https://hal.archives-ouvertes.fr/inserm-00286442

O. Manches, D. Munn, A. Fallahi, J. Lifson, L. Chaperot et al., P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism, Retrovirology, vol.6, issue.Suppl 3, pp.3431-3440, 2008.
DOI : 10.1186/1742-4690-6-S3-P281

URL : https://hal.archives-ouvertes.fr/inserm-00651123

D. Domizio, J. Blum, A. Gallagher-gambarelli, M. Molens, J. Chaperot et al., TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN, Blood, vol.114, issue.9, pp.1794-802, 2009.
DOI : 10.1182/blood-2009-04-216770

URL : https://hal.archives-ouvertes.fr/inserm-00419344

C. Aspord, J. Charles, M. Leccia, D. Laurin, M. Richard et al., A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells, PLoS ONE, vol.5, issue.5, p.10458, 2010.
DOI : 10.1371/journal.pone.0010458.s010

URL : https://hal.archives-ouvertes.fr/inserm-00484505

C. Aspord, D. Laurin, M. Richard, H. Vie, L. Chaperot et al., Induction of Antiviral Cytotoxic T Cells by Plasmacytoid Dendritic Cells for Adoptive Immunotherapy of Posttransplant Diseases, American Journal of Transplantation, vol.5, issue.12, 2011.
DOI : 10.1111/j.1600-6143.2011.03722.x

P. Fisicaro, C. Valdatta, M. Massari, E. Loggi, E. Biasini et al., Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B, Gastroenterology, vol.138, issue.2, pp.682-93, 2010.
DOI : 10.1053/j.gastro.2009.09.052

J. Luo, J. Li, R. Chen, L. Nie, J. Huang et al., Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers, Vaccine, vol.28, issue.13, pp.2497-504, 2010.
DOI : 10.1016/j.vaccine.2010.01.038

E. Ilan, J. Arazi, O. Nussbaum, A. Zauberman, R. Eren et al., The Hepatitis C Virus (HCV)???Trimera Mouse: A Model for Evaluation of Agents against HCV, The Journal of Infectious Diseases, vol.185, issue.2, pp.153-61, 2002.
DOI : 10.1086/338266